Navigation Links
Gardasil, Other New Products Spur Strong Vaccine Sales in 2007
Date:4/7/2008

NEW YORK, April 7, 2008 /PRNewswire/ -- Stronger than anticipated revenues for flu vaccines, and the surprising commercial success of Merck's Gardasil for HPV, which causes most cervical cancers, has led to a healthy $16.3 billion in vaccine sales in 2007. This represents an increase of 38% over 2006 sales of $11.7 billion, according to Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, a new market research study and reforecast of the vaccine market from Kalorama Information.

According to the report, new products approved in recent years, in particular Gardasil, but also RotaTeq, Pentacel, Zostavax and FluMist, are now having an impact on the market. These new products, combined with a continued emphasis on flu vaccines in the U.S. healthcare system, have created a healthy environment for vaccine products.

Five major players -- Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Wyeth and Novartis -- dominate vaccine sales. At these companies, as well as smaller producers, Kalorama Information has found increased interest in vaccines, and a willingness to look at products for conditions not historically addressed with vaccines, including diabetes, cancer and smoking cessation. Given this trend and strong sales, Kalorama Information expects vaccine sales to more than double in five years.

"You might call it a 'Gardasil Effect'," says Bruce Carlson, publisher of Kalorama Information. "R&D departments are more confident about investing in a vaccine product now than in the past because a strong marketing precedent has been established. Expect to see new vaccine products, and perhaps new companies in the market."

Kalorama Information's new report Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry reforecasts the market for this highly profitable drug segment and addresses the dramatic changes taking place. The report covers current world revenues and forecasts through 2013 for pediatric and adult vaccines, and provides pipeline analysis and company profiles. The report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Vaccines-Key-Players-1682234/.

About Kalorama Information

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. Kalorama routinely assists media with healthcare topics, and can provide experts to speak about markets in the life sciences industry. For more information, contact Andrea Hiller at 212-807-2673 or press@kaloramainformation.com, or visit http://www.kaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Identification of dopamine mother cells could lead to future Parkinsons treatments
2. Mother-Child Bond Affects Quality of Conflict Resolution
3. Snack Brothers Distributors to Sell New HEALTHYCAL+ Bottled Water
4. Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Competes in Ironman Arizona in Tempe
5. Comfort C(R) Provides Significantly Higher Absorption Than Other Leading Brand
6. Fetal Cells Detected in Mothers Blood Years After Donor Egg Pregnancies
7. Wounded Warriors Rig for Skiing, Rock Climbing, Other Winter Sports
8. Mother-child attachment, childrens temperament play a role in terrible 2 conflicts
9. YogaPro Celebrates Mothers Day with a Photo Contest to Win YogaToes(R) Foot Care Exercisers to Soothe and Beautify Moms Feet
10. Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions
11. RxElite Awarded Anesthetic Gases Multi-Source Contract by Premier Inc., a Purchasing Network for More than 1,500 U.S. Hospitals and 49,000 Other Healthcare Sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... its certification exam and eligibility requirements effective with the April 2017 testing period. ... 1995. , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a ... skipping doses or not filling a prescription because they could not afford to ... problems getting medications were 30-60%*. At the same time, hospitals, pharmacies, ...
(Date:2/22/2017)... Colorado (PRWEB) , ... February ... ... the availability of their newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” ... delivery system®, which provides instant absorption from the mouth into the bloodstream. ...
(Date:2/22/2017)... WV (PRWEB) , ... February 22, 2017 , ... ... awarded a contract to Quality Insights to help small practices in Delaware, New ... Payment Program, established by the Medicare Access and CHIP Reauthorization Act of 2015 ...
(Date:2/22/2017)... ... February 22, 2017 , ... Michael ... new media platform connecting healthcare technology professionals and other key stakeholders with an ... quarterly publication starting on March 1, announced Michael J. Hennessy, Jr., president of ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... -- Andre, DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ... and products, commented on ADMT,s third quarter fiscal year ... the Company,s quarterly report on Form 10Q available at ... stated "During the quarter ended December 31, 2016 we ... portion of our engineering efforts into the development of ...
(Date:2/22/2017)... , Feb. 22, 2017 Summary ... infarction partnering deals and agreements entered into by ... full report: http://www.reportlinker.com/p03605670-summary/view-report.html Description The ... understanding and access to partnering deals and agreements ... - Trends in partnering deals ...
(Date:2/22/2017)... 22, 2017 Summary Provides ... partnering deals and agreements entered into by the ... report: http://www.reportlinker.com/p03605673-summary/view-report.html Description The Global ... understanding and access to partnering deals and agreements ... - Trends in partnering deals ...
Breaking Medicine Technology: